Sonia Dutta, MD
Urogynecology and Reconstructive Pelvic Surgery · Skokie, ILNPI 1841599255
Payments from drug & device makers
What this record shows
Medtronic accounts for 63.0% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $1,349, more than ten times the $51 reported in 2019. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in IL, where the typical reported total is $2,778.
Across 40 payments — averaging $53.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Boston Scientific$455
- Axonics, Inc.$111
- ABB Con-cise Optical Group LLC$77
- AbbVie$69
- Convatec Inc.$34
- plus $40 from 3 others
Across 5 payments — averaging $85.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$426
What the payments were for
- Travel & lodging$94945%
- Food & beverage$1,17855%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 19 | $1,341 |
| Boston Scientific | 8 | $455 |
| Axonics, Inc. | 4 | $111 |
| ABB Con-cise Optical Group LLC | 1 | $77 |
| AbbVie(2 entities) | 3 | $69 |
| Convatec Inc. | 2 | $34 |
| Hollister Incorporated | 1 | $22 |
| Antares Pharma, Inc. | 1 | $16 |
| THD America, Inc. | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALTAVIVA$943
- Advantage System$103
How this compares
$2,128 in reported general payments places this provider in the 40th percentile of 62 urogynecology and reconstructive pelvic surgery providers in Illinois.
See all urogynecology and reconstructive pelvic surgery providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 469 | $396,836 |
| GemtesaVibegron | 81 | $70,368 |
| Mirabegron ErMirabegron | 38 | $28,258 |
| BotoxOnabotulinumtoxina | 25 | $21,792 |
| Estradiol | 213 | $13,581 |
| Solifenacin Succinate | 308 | $13,056 |
| Trospium Chloride ErTrospium Chloride | 99 | $13,016 |
| EstringEstradiol | 14 | $7,206 |
| Methenamine Hippurate | 87 | $6,564 |
| Trimethoprim | 71 | $5,724 |
| PremarinEstrogens, Conjugated | 13 | $5,504 |
| Trospium Chloride | 149 | $4,490 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 23 | $2,699 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 179 | $2,634 |
| Fosfomycin Tromethamine | 19 | $2,493 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieBotox | $69 | $21,79225 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 62 urogynecology and reconstructive pelvic surgery providers in Illinois.
Other urogynecology and reconstructive pelvic surgery in Skokie
- Peter SandSkokie$185K
- Roger GoldbergSkokie$54K
- Adam Gafni KaneSkokie$7K
- Nani MossSkokie$5K
- Janet TomezskoSkokie$1K
- Ghazaleh Rostami NiaSkokie$735
- Cynthia BrincatSkokie$37
- Abraham ShashouaChicago$339K
- Akira GillinghamChicago$58K
- Kimberly KentonChicago$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.